Hedayati Goudarzi M, Moradi M, Abrotan S, Saravi M, Shirafkan H, Irilouzadian R
Cardiol Res Pract. 2024; 2023:4552100.
PMID: 38204930
PMC: 10781524.
DOI: 10.1155/2023/4552100.
Lu J, Fan Z, Li Y, Wang Z, Ma L, Yuan B
Front Cardiovasc Med. 2022; 9:1054199.
PMID: 36568560
PMC: 9772473.
DOI: 10.3389/fcvm.2022.1054199.
Novo Matos J, Payne J, Seo J, Luis Fuentes V
J Vet Intern Med. 2022; 36(6):1900-1912.
PMID: 36315028
PMC: 9708425.
DOI: 10.1111/jvim.16576.
Mandes L, Rosca M, Ciuperca D, Popescu B
J Echocardiogr. 2020; 18(3):137-148.
PMID: 32301048
PMC: 7473965.
DOI: 10.1007/s12574-020-00467-9.
Songsirisuk N, Kittipibul V, Methachittiphan N, Charoenattasil V, Zungsontiporn N, Spanuchart I
BMC Cardiovasc Disord. 2019; 19(1):1.
PMID: 30606129
PMC: 6318850.
DOI: 10.1186/s12872-018-0984-0.
Risk stratification in hypertrophic cardiomyopathy.
Marrakchi S, Kammoun I, Bennour E, Laroussi L, Kachboura S
Herz. 2018; 45(1):50-64.
PMID: 29696341
DOI: 10.1007/s00059-018-4700-8.
Implantable cardioverter defibrillators in the context of hypertrophic cardiomyopathy: a lesson in patient autonomy.
Bray J, Bucciarelli-Ducci C, Stuart G
BMJ Case Rep. 2018; 2018.
PMID: 29437742
PMC: 5836676.
DOI: 10.1136/bcr-2017-223352.
Women with hypertrophic cardiomyopathy have worse survival.
Geske J, Ong K, Siontis K, Hebl V, Ackerman M, Hodge D
Eur Heart J. 2017; 38(46):3434-3440.
PMID: 29020402
PMC: 6251550.
DOI: 10.1093/eurheartj/ehx527.
ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.
Trivedi A, Knight B
Arrhythm Electrophysiol Rev. 2017; 5(3):188-196.
PMID: 28116084
PMC: 5248664.
DOI: 10.15420/aer.2016:30:2.
Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.
Kim S, Ko S, Choi S, Choi B, Stillman A
Int J Cardiovasc Imaging. 2016; 32 Suppl 1:21-43.
PMID: 27139460
DOI: 10.1007/s10554-016-0891-3.
Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.
Villa A, Sammut E, Zarinabad N, Carr-White G, Lee J, Bettencourt N
J Cardiovasc Magn Reson. 2016; 18:4.
PMID: 26767610
PMC: 4714488.
DOI: 10.1186/s12968-016-0223-8.
Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.
van der Lee C, Kofflard M, Geleijnse M, Ten Cate F
Neth Heart J. 2015; 13(12):452-460.
PMID: 25696443
PMC: 2497370.
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy.
Elliott P, Gimeno J, Thaman R, Shah J, Ward D, Dickie S
Heart. 2005; 92(6):785-91.
PMID: 16216855
PMC: 1860645.
DOI: 10.1136/hrt.2005.068577.
Comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in Korea.
Yang H, Song J, Song J, Kang D, Lee C, Hong M
Korean J Intern Med. 2005; 20(2):111-5.
PMID: 16134764
PMC: 3891378.
DOI: 10.3904/kjim.2005.20.2.111.
Hypertrophic cardiomyopathy associated with left ventricular aneurysm and normal coronary arteries: Case study indicating genetic tendencies of cardiomyopathy.
Saenz de la Calzada C, Verdugo A, Perez J, Alcaine C, Fernandez A
Cardiovasc Dis. 1981; 8(1):73-83.
PMID: 15216229
PMC: 287903.
On predictors of sudden cardiac death in hypertrophic cardiomyopathy.
Marian A
J Am Coll Cardiol. 2003; 41(6):994-6.
PMID: 12651047
PMC: 2887726.
DOI: 10.1016/s0735-1097(02)03003-6.
Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study.
Buell H, Stables R, DeLong E, Shuping K, Killip D, Lever H
J Med Syst. 2002; 26(4):293-300.
PMID: 12118813
DOI: 10.1023/a:1015812603042.
Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron B
Heart. 1998; 79(4):331-6.
PMID: 9616338
PMC: 1728662.
DOI: 10.1136/hrt.79.4.331.
Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.
Lip G
Postgrad Med J. 1996; 72(854):731-8.
PMID: 9015466
PMC: 2398676.
DOI: 10.1136/pgmj.72.854.731.
Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy.
Ikeda U, Yamamoto K, Shimada K
Clin Cardiol. 1997; 20(1):7-10.
PMID: 8994731
PMC: 6656130.
DOI: 10.1002/clc.4960200104.
